Addressing the underuse of adrenaline in anaphylaxis requires immediate action and collaboration from all stakeholders. A recent review paper raised action points we must address to make a positive impact and help save lives. Here’s what we can do:

1. Education and Training: Healthcare providers must stay well-informed about the latest guidelines and recommendations for adrenaline use. Continuous education and training empower them to confidently administer adrenaline, potentially saving lives during severe allergic reactions. Check out the new anaphylaxis action plan at www.allergyfoundation.co.za
2. Empower Patients and Caregivers: Educating patients and caregivers about anaphylaxis recognition and the proper use of adrenaline auto-injectors is essential. Knowledge enables them to take immediate action during allergic emergencies and effectively manage severe allergies. All patients at risk, should have a medical labelling band, such as a Mediband, and carry adrenaline at all times.
3. Raise Awareness: Public awareness campaigns are crucial to help our communities to understand the severity of anaphylaxis and the importance of timely adrenaline administration. Spreading awareness ensures that those in need can receive rapid assistance during an allergic reaction.
4. Collaborative Efforts: Addressing the underuse of adrenaline requires a united effort from healthcare providers, patients, advocacy groups, and policymakers. By working together, we can establish adrenaline as the standard treatment for anaphylaxis and protect those with severe allergies.

Dispelling Misconceptions
In addition to taking action, it is vital to dispel misconceptions surrounding adrenaline use during anaphylactic reactions. Let’s clear up the following misconceptions:

1. Misconception #1: Adrenaline is unsafe for people with heart problems: The benefits of using adrenaline outweigh the potential risks, including for those individuals with a history of cardiovascular disease.
2. Misconception #2: Adrenaline Auto-Injectors (EAIs) are not safe for infants: EAIs are designed for use in young children and can be life-saving during anaphylactic emergencies.
3. Misconception #3: Adrenaline Auto-Injectors (EAIs) are harmful: When used correctly, EAIs deliver a precise dose of adrenaline, and are not harmful.
4. Misconception #4: Using adrenaline requires a visit to the emergency department: Seeking medical attention after using adrenaline is essential for thorough evaluation and follow-up care, not because adrenaline is dangerous.

Conclusion: Taking a Stand Against Anaphylaxis

Let’s take a stand against anaphylaxis and work together to improve adrenaline utilisation. By addressing underuse, dispelling misconceptions, and collaborating as a community, we can make a significant impact on the lives of those affected by severe allergies. Prompt adrenaline administration should be the norm, ensuring the safety and well-being of our patients.

For more information or to create an anaphylaxis action plan, please see www.allergyfoundation.co.za.

Reference: Journal of Asthma and Allergy “Underuse of adrenaline for the treatment of anaphylaxis: missed opportunities”